Zevra Therapeutics
ZVRA
#7256
Rank
A$0.71 B
Marketcap
A$12.71
Share price
-1.52%
Change (1 day)
-7.65%
Change (1 year)

Earnings for Zevra Therapeutics (ZVRA)

Earnings in 2025 (TTM): A$92.45 Million

According to Zevra Therapeutics's latest financial reports the company's current earnings are A$84.38 Million. In 2024 the company made an earning of -A$0.13 Billion a decrease over its 2023 earnings that were of -A$59.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Zevra Therapeutics from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$92.45 M-174.25%
2024 -A$0.13 Billion107.97%
2023 -A$59.88 Million-5.55%
2022 -A$63.4 Million418.02%
2021 -A$12.24 Million44.87%
2020 -A$8.45 Million-68.85%
2019 -A$27.12 Million-63.58%
2018 -A$74.47 Million37.16%
2017 -A$54.29 Million283.79%
2016 -A$14.15 Million-81.21%
2015 -A$75.3 Million130.03%
2014 -A$32.74 Million